Old Web
English
Sign In
Acemap
>
Paper
>
Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
2021
Dimitrios Giannis
James D. Douketis
Alex C. Spyropoulos
Keywords:
severe acute respiratory syndrome coronavirus 2
Medicine
Intensive care medicine
Thrombosis
Coronavirus disease 2019
2019 20 coronavirus outbreak
anticoagulant therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
18
References
0
Citations
NaN
KQI
[]